You can buy or sell MNLO and other stocks, options, ETFs, and crypto commission-free!
Menlo Therapeutics Inc. Common Stock, also called Menlo Therapeutics, is focused on the development and commercialization of serlopitant for the treatment of pruritus, or itch, associated with dermatologic conditions such as atopic dermatitis, psoriasis and prurigo nodularis. Read More The company was founded in October, 2011 and is headquartered in Redwood City, CA.
Redwood City, California
52 Week High
52 Week Low
Expected Nov 6, After Hours